STEPHAN DIETRICH A (President and CEO) exercised options at NEUBASE THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/15/2023ACC: 0001104659-23-022495
DirectorOfficer· President and CEO
Since Jul 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
655K acquired · 655K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+655K
Price / share
—
Trade value
—
% of position
80.2%
2/13/2023
816.77K→1.47M
Total
Net shares
+655K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2023 | M · Option Exercise | +655K | — | — | 80.2% | 816.77K | 1.47M |
| Total | +655K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
655K shares
Shares
−655K
Strike price
0.00
Held after
1.86M
Exercisable
—
2/13/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock655K shares | 2/13/2023 | M · Option Exercise | −655K | 0.00 | — | 1.86M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.27M
Total
1.27M indirect1.27M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.27M | Indirect |
| Total | 1.27M | 1.27M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported